chr5-159315942-T-G

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1

The NM_002187.3(IL12B):​c.*159A>C variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.264 in 152,312 control chromosomes in the GnomAD database, including 5,876 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.26 ( 5870 hom., cov: 33)
Exomes 𝑓: 0.24 ( 6 hom. )

Consequence

IL12B
NM_002187.3 3_prime_UTR

Scores

2

Clinical Significance

Benign criteria provided, single submitter B:1

Conservation

PhyloP100: -0.218

Publications

447 publications found
Variant links:
Genes affected
IL12B (HGNC:5970): (interleukin 12B) This gene encodes a subunit of interleukin 12, a cytokine that acts on T and natural killer cells, and has a broad array of biological activities. Interleukin 12 is a disulfide-linked heterodimer composed of the 40 kD cytokine receptor like subunit encoded by this gene, and a 35 kD subunit encoded by IL12A. This cytokine is expressed by activated macrophages that serve as an essential inducer of Th1 cells development. This cytokine has been found to be important for sustaining a sufficient number of memory/effector Th1 cells to mediate long-term protection to an intracellular pathogen. Overexpression of this gene was observed in the central nervous system of patients with multiple sclerosis (MS), suggesting a role of this cytokine in the pathogenesis of the disease. The promoter polymorphism of this gene has been reported to be associated with the severity of atopic and non-atopic asthma in children. [provided by RefSeq, Jul 2008]
IL12B Gene-Disease associations (from GenCC):
  • Mendelian susceptibility to mycobacterial diseases due to complete IL12B deficiency
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.86).
BP6
Variant 5-159315942-T-G is Benign according to our data. Variant chr5-159315942-T-G is described in ClinVar as Benign. ClinVar VariationId is 352569.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.449 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_002187.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
IL12B
NM_002187.3
MANE Select
c.*159A>C
3_prime_UTR
Exon 8 of 8NP_002178.2

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
IL12B
ENST00000231228.3
TSL:1 MANE Select
c.*159A>C
3_prime_UTR
Exon 8 of 8ENSP00000231228.2
IL12B
ENST00000696751.1
n.*641A>C
non_coding_transcript_exon
Exon 7 of 7ENSP00000512850.1
IL12B
ENST00000696750.1
c.*159A>C
3_prime_UTR
Exon 5 of 5ENSP00000512849.1

Frequencies

GnomAD3 genomes
AF:
0.264
AC:
40196
AN:
152050
Hom.:
5863
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.338
Gnomad AMI
AF:
0.196
Gnomad AMR
AF:
0.334
Gnomad ASJ
AF:
0.167
Gnomad EAS
AF:
0.464
Gnomad SAS
AF:
0.363
Gnomad FIN
AF:
0.179
Gnomad MID
AF:
0.291
Gnomad NFE
AF:
0.200
Gnomad OTH
AF:
0.285
GnomAD4 exome
AF:
0.243
AC:
35
AN:
144
Hom.:
6
Cov.:
0
AF XY:
0.225
AC XY:
18
AN XY:
80
show subpopulations
African (AFR)
AC:
0
AN:
0
American (AMR)
AC:
0
AN:
0
Ashkenazi Jewish (ASJ)
AC:
0
AN:
0
East Asian (EAS)
AF:
0.246
AC:
32
AN:
130
South Asian (SAS)
AC:
0
AN:
0
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
2
Middle Eastern (MID)
AC:
0
AN:
0
European-Non Finnish (NFE)
AF:
0.250
AC:
3
AN:
12
Other (OTH)
AC:
0
AN:
0
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.492
Heterozygous variant carriers
0
1
2
4
5
6
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.264
AC:
40228
AN:
152168
Hom.:
5870
Cov.:
33
AF XY:
0.269
AC XY:
19977
AN XY:
74402
show subpopulations
African (AFR)
AF:
0.337
AC:
13997
AN:
41504
American (AMR)
AF:
0.334
AC:
5108
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.167
AC:
579
AN:
3470
East Asian (EAS)
AF:
0.465
AC:
2405
AN:
5176
South Asian (SAS)
AF:
0.363
AC:
1747
AN:
4808
European-Finnish (FIN)
AF:
0.179
AC:
1897
AN:
10592
Middle Eastern (MID)
AF:
0.286
AC:
84
AN:
294
European-Non Finnish (NFE)
AF:
0.200
AC:
13626
AN:
68004
Other (OTH)
AF:
0.287
AC:
607
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1495
2990
4485
5980
7475
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
410
820
1230
1640
2050
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.233
Hom.:
7369
Bravo
AF:
0.281
Asia WGS
AF:
0.432
AC:
1497
AN:
3476

ClinVar

Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Mendelian susceptibility to mycobacterial diseases due to complete IL12B deficiency Benign:1
Mar 06, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease.

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.86
CADD
Benign
1.3
DANN
Benign
0.46
PhyloP100
-0.22
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3212227; hg19: chr5-158742950; API